{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:23:45Z","timestamp":1790256225714,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00428-019-02599-5","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T15:02:32Z","timestamp":1560956552000},"page":"637-648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Two cases of phenotypic switch of primary cutaneous T cell lymphoma after treatment with an aggressive course and review of the literature"],"prefix":"10.1007","volume":"475","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4601-0285","authenticated-orcid":false,"given":"Etan","family":"Marks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,19]]},"reference":[{"key":"2599_CR1","first-page":"217","volume":"85","author":"P Cappelaere","year":"1998","unstructured":"Cappelaere P (1998) Les lymphomes non hodgkiniens secondaires. Bull Cancer 85:217\u2013231","journal-title":"Bull Cancer"},{"key":"2599_CR2","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1046\/j.1365-2141.2002.03655.x","volume":"118","author":"M Libra","year":"2002","unstructured":"Libra M, De Re V, Gasparotto D et al (2002) Differentiation between non-Hodgkin's lymphoma recurrence and second primary lymphoma by VDJ rearrangement analysis. Br J Haematol 118:809\u2013812","journal-title":"Br J Haematol"},{"key":"2599_CR3","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1182\/blood.V78.5.1327.1327","volume":"78","author":"CH Pui","year":"1991","unstructured":"Pui CH, Raimondi SC, Head DR et al (1991) Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood 78:1327\u20131337","journal-title":"Blood"},{"issue":"1","key":"2599_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/sj.leu.2401948","volume":"15","author":"W Leung","year":"2001","unstructured":"Leung W, Ribeiro RC, Hudson M, Tong X, Srivastava DK, Rubnitz JE, Sandlund JT, Razzouk BI, Evans WE, Pui CH (2001) Second malignancy after treatment of childhood acute myeloid leukemia. Leukemia. 15(1):41\u201345","journal-title":"Leukemia."},{"issue":"1","key":"2599_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/his.13196","volume":"71","author":"E Marks","year":"2017","unstructured":"Marks E, Shi Y, Wang Y (2017 Jul) CD117 (KIT) is a useful marker in the diagnosis of plasmablastic plasma cell myeloma. Histopathology. 71(1):81\u201388","journal-title":"Histopathology."},{"key":"2599_CR6","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","volume":"113","author":"PT Bradford","year":"2009","unstructured":"Bradford PT, Devesa SS, Anderson WF, Toro JR (2009) Cutaneous lymphoma incidence patterns in the United States: a population- based study of 3884 cases. Blood 113:5064\u20135073","journal-title":"Blood"},{"key":"2599_CR7","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","volume":"28","author":"NS Agar","year":"2010","unstructured":"Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A, Webb K, Scarisbrick J, Morris S, Whittaker SJ (2010) Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol 28:4730\u20134739","journal-title":"J Clin Oncol"},{"issue":"1","key":"2599_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/cup.12252","volume":"41","author":"PP Aung","year":"2014","unstructured":"Aung PP, Climent F, Muzzafar T, Curry JL, Patel KP, Servitje O, Prieto VG, Duvic M, Jaffe ES, Torres-Cabala CA (2014) Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases. J Cutan Pathol 41(1):51\u201357","journal-title":"J Cutan Pathol"},{"key":"2599_CR9","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/bjd.14723","volume":"175","author":"C Endo","year":"2016","unstructured":"Endo C, Naka Y, Miyagaki T, Fujita H, Sugaya M, Kawashima M, Tsunemi Y (2016) Immunophenotypic shift from CD4+ to CD8+ in mycosis fungoides. Br J Dermatol 175:830\u2013833","journal-title":"Br J Dermatol"},{"key":"2599_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1365-2133.2009.09541.x","volume":"162","author":"S Okada","year":"2010","unstructured":"Okada S, Nannya Y, Ota S, Takazawa Y, Yamamoto G, Kumano K, Izutsu K, Takahashi T, Chiba S, Kurokawa M (2010) Cutaneous T-cell lymphoma (mycosis fungoides) relapsed with different immunological phenotype after bone marrow transplant. Br J Dermatol 162:229\u2013230","journal-title":"Br J Dermatol"},{"key":"2599_CR11","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jaad.2005.06.044","volume":"53","author":"A Kreuter","year":"2005","unstructured":"Kreuter A, Altmeyer P (2005) Rapid onset of CD8+ aggressive T-cell lymphoma during bexarotene therapy in a patient with S\u00e9zary syndrome. J Am Acad Dermatol 53:1093\u20131095","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"2599_CR12","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ad.2016.04.006","volume":"107","author":"\u00c1 Vargas Nevado","year":"2016","unstructured":"Vargas Nevado \u00c1, L\u00f3pez Navarro N, Gallego Dom\u00ednguez E, Herrera Ceballos E (2016) Immunophenotypic shift associated with Angiocentricity and Cytoxic characteristics in a case of mycosis Fungoides. Actas Dermosifiliogr 107(8):697\u2013699","journal-title":"Actas Dermosifiliogr"},{"issue":"11","key":"2599_CR13","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1097\/DAD.0000000000000609","volume":"38","author":"WT Johnson","year":"2016","unstructured":"Johnson WT, Leeman-Neill RJ, Patel P, Ho J, Grandinetti LM, Jedrych J, Craig FE (2016) Fatal case of primary cutaneous aggressive T-cell lymphoma switching from a CD4+ to a CD8+ phenotype: progressive disease with Bexarotene and Romidepsin treatment. Am J Dermatopathol 38(11):832\u2013837","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"2599_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1034\/j.1600-0560.2001.028004174.x","volume":"28","author":"J Guitart","year":"2001","unstructured":"Guitart J, Kennedy J, Ronan S, Chmiel JS, Hsiegh YC, Variakojis D (2001) Histologic criteria for the diagnosis of mycosis fungoides: proposal for a grading system to standardize pathology reporting. J Cutan Pathol 28(4):174\u2013183","journal-title":"J Cutan Pathol"},{"issue":"2","key":"2599_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2353\/jmoldx.2010.090042","volume":"12","author":"KP Patel","year":"2010","unstructured":"Patel KP, Pan Q, Wang Y, Maitta RW, Du J, Xue X, Lin J, Ratech H (2010) Comparison of BIOMED-2 versus laboratory-developed polymerase chain reaction assays for detecting T-cell receptor-gamma gene rearrangements. J Mol Diagn 12(2):226\u2013237","journal-title":"J Mol Diagn"},{"issue":"3","key":"2599_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.5858\/arpa.2014-0018-CP","volume":"139","author":"R Dewar","year":"2015","unstructured":"Dewar R, Andea AA, Guitart J, Arber DA, Weiss LM (2015) Best practices in diagnostic immunohistochemistry: workup of cutaneous lymphoid lesions in the diagnosis of primary cutaneous lymphoma. Archives of Pathology & Laboratory Medicine 139(3):338\u2013350","journal-title":"Archives of Pathology & Laboratory Medicine"},{"issue":"4","key":"2599_CR17","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1309\/AJCPOBDP2OQAJ5BR","volume":"139","author":"SX Song","year":"2013","unstructured":"Song SX, Willemze R, Swerdlow SH, Kinney MC, Said JW (2013) Mycosis Fungoides: report of the 2011 Society for Hematopathology\/European Association for Haematopathology Workshop. Am J Clin Pathol 139(4):466\u2013490","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2599_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1046\/j.1365-2133.2003.05015.x","volume":"148","author":"M Nikolova","year":"2003","unstructured":"Nikolova M, Echchakir H, Wechsler J, Boumsell L, Bensussan A, Bagot M (2003) Isolation of a CD8alphaalpha+ CD4- tumour T-cell clone with cytotoxic activity from a CD4+ CD8- cutaneous T-cell lymphoma. Br J Dermatol 148(1):24\u201329","journal-title":"Br J Dermatol"},{"issue":"1","key":"2599_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1472-6890-2-5","volume":"2","author":"LT Washington","year":"2002","unstructured":"Washington LT, Huh YO, Powers LC, Duvic M (2002) Jones D. a stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy. BMC Clin Pathol 2(1):5","journal-title":"BMC Clin Pathol"},{"issue":"4","key":"2599_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/PAS.0000000000000786","volume":"41","author":"RL Agbay","year":"2017","unstructured":"Agbay RL, Torres-Cabala CA, Patel KP et al (2017) Immunophenotypic shifts in primary cutaneous \u03b3\u03b4 T-cell lymphoma suggest antigenic modulation: a study of sequential biopsy specimens. Am J Surg Pathol 41(4):431\u2013445","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"2599_CR21","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/cup.12830","volume":"43","author":"J Guitart","year":"2016","unstructured":"Guitart J, Martinez EME (2016) \u03b3\u03b4 T-cell in cutaneous and subcutaneous lymphoid infiltrates: malignant or not. J Cutan Pathol 43(12):1242\u20131244","journal-title":"J Cutan Pathol"},{"issue":"2","key":"2599_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/PAS.0000000000000768","volume":"41","author":"ED Merrill","year":"2017","unstructured":"Merrill ED, Agbay R, Miranda RN, Aung PP, Tetzlaff MT, Young KH, Curry JL, Nagarajan P, Ivan D, Prieto VG, Medeiros LJ, Duvic M, Torres-Cabala CA (2017) Primary cutaneous T-cell lymphomas showing Gamma-Delta (\u03b3\u03b4) phenotype and predominantly Epidermotropic pattern are Clinicopathologically distinct from classic primary cutaneous \u03b3\u03b4 T-cell lymphomas. Am J Surg Pathol 41(2):204\u2013215","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2599_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.mpdhp.2016.04.004","volume":"22","author":"P Virmani","year":"2016","unstructured":"Virmani P, Myskowski PL, Pulitzer M (2016) Unusual variants of mycosis fungoides. Diagn Histopathol (Oxf) 22(4):142\u2013151","journal-title":"Diagn Histopathol (Oxf)"},{"issue":"9","key":"2599_CR24","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1182\/blood.V100.9.3369","volume":"100","author":"F Vega","year":"2002","unstructured":"Vega F, Luthra R, Medeiros LJ et al (2002) Clonal heterogeneity in mycosis fungoides and its relationship to clinical course. Blood. 100(9):3369\u20133373","journal-title":"Blood."},{"issue":"9","key":"2599_CR25","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.4049\/jimmunol.145.9.2797","volume":"145","author":"L Boumsell","year":"1990","unstructured":"Boumsell L, Schmid M, Dastot H, Gouttefangeas C, Mathieu-Mahul D, Bensussan A (1990) In vitro differentiation from a pluripotent human CD4+CD8+ thymic cloned cell into four phenotypically distinct subsets. J Immunol 145(9):2797\u20132802","journal-title":"J Immunol"},{"issue":"4","key":"2599_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11864-003-0004-0","volume":"4","author":"L Sokol","year":"2003","unstructured":"Sokol L, Loughran TP Jr (2003) Large granular lymphocyte leukemia and natural killer cell leukemia\/lymphomas. Curr Treat Options in Oncol 4(4):289\u2013296","journal-title":"Curr Treat Options in Oncol"},{"issue":"4","key":"2599_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/MOH.0b013e3283623c61","volume":"20","author":"JE Haydu","year":"2013","unstructured":"Haydu JE, Ferrando AA (2013) Early T-cell precursor acute lymphoblastic leukaemia. Curr Opin Hematol 20(4):369\u2013373","journal-title":"Curr Opin Hematol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02599-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-019-02599-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02599-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T15:50:35Z","timestamp":1694965835000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-019-02599-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,19]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2599"],"URL":"https:\/\/doi.org\/10.1007\/s00428-019-02599-5","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,19]]},"assertion":[{"value":"5 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All three authors made substantial contributions to the conception and design of the work as well as the acquisition, analysis, and interpretation of data for the work. All authors participated in drafting the work and revising it critically for important intellectual content. All authors gave final approval of the version submitted and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}